YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCFL0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $89,082
Award facts
- Contract value 100% obligated
- $89,081.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $89,081.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vial format on November 25, 2025. The delivery order is scheduled for completion by December 17, 2025, and does not utilize a set-aside designation, allowing the award to compete in unrestricted federal procurement. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the sole prime contractor with no identified subcontractor relationships.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying contract, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and authorizes DLA to issue delivery orders for comprehensive pharmaceutical products to support Department of Defense medical supply requirements through December 31, 2036. The PPV-G GEN V program is a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FCFL0?
SPE2DR26FCFL0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FCFL0 worth?
The government has obligated $89,082 on SPE2DR26FCFL0.
Is contract SPE2DR26FCFL0 an order under another contract?
Yes. SPE2DR26FCFL0 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFL0 competed?
The extent of competition for SPE2DR26FCFL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award